Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

December 31, 2013

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Pirfenidone

Pirfenidone(200mg)tablets will be taken two tablets 3 times a day during the whole study process.

DRUG

placebo

placebo will be taken two tablets 3 times a day during the whole study process

All Listed Sponsors
collaborator

Nanjing Chia-tai Tianqing Pharmaceutical

INDUSTRY

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER